Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory diseases, including acute respiratory distress syndrome and acute lung injury. Give...

Full description

Bibliographic Details
Main Authors: Karakaş, N. (Author), Karaoğlan, B.S (Author), Öztürk, G. (Author), Shah, K. (Author), Üçüncüoğlu, S. (Author), Uludağ, D. (Author)
Format: Article
Language:English
Published: MDPI 2022
Subjects:
ACE2
adult respiratory distress syndrome
angiotensin converting enzyme 2
Angiotensin-Converting Enzyme 2
Article
bioengineering
Bioengineering
computer assisted tomography
coronavirus disease 2019
COVID-19
CRISPR Cas system
cytokine
cytokine production
cytokine storm
Cytokines
cytology
dimerization
double stranded DNA break
epidemiology
fluorescence activated cell sorting
gamma interferon
gamma interferon inducible protein 10
ganciclovir
gene knockout
gene silencing
genetic engineering
Genetic engineering
genetic transfection
genetics
granulocyte colony stimulating factor
HPN protein, human
human
Humans
immunomodulation
interleukin 10
interleukin 17
interleukin 1beta
interleukin 4
interleukin 5
interleukin 6
interleukin 8
lung
Lung
mesenchymal stem cell
mesenchymal stem cell transplantation
Mesenchymal Stem Cell Transplantation
Mesenchymal stem cells
Mesenchymal Stem Cells
mesenchymal stromal cell therapy
metabolism
monocyte chemotactic protein 1
monocyte chemotactic protein 4
monolayer culture
nonhuman
pandemic
Pandemics
pathology
physiology
plasmid DNA
procedures
SARS-CoV-2
Serine Endopeptidases
serine proteinase
Severe acute respiratory syndrome coronavirus 2
therapy
TMPRSS2
transmembrane protease serine 2
treatment outcome
Treatment Outcome
virology
virus replication
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items